Graduate studies at Western
|Abstract||If the contributions of a relatively young and a relatively old candidate are recognized as Nobel-worthy at the same time, will the older candidate receive the award earlier in view of his/her lower life expectancy? Estimates from an econometric model based on a panel dataset from 1901 to 2007 suggest an age premium associated with older candidates. Specifically, the results show that making the Nobel-worthy contribution a year later delays the Prize by about six months, while sharing the Nobel Prize reduces the age at which the candidate is awarded the Nobel by almost 2 years. The results also suggest that the Nobel committee rushed the Prize to older candidates during the first decade of the Nobel. Similarly, a positive and highly significant time trend may reflect the expanding pool of candidates (and hence older candidates) as the population and the number of educated people rises, and life expectancy increases. Networking seems to matter, with the Prize being accelerated by 7 months for each alive Laureate in the same institution (and field). Other factors such as gender and the country of the Nobel-worthy research do not have a noticeable impact.|
|Keywords||No keywords specified (fix it)|
No categories specified
(categorize this paper)
|Through your library||Only published papers are available at libraries|
Similar books and articles
Rachel Lewinsohn (2003). Prophet in His Own Country: Carlos Chagas and the Nobel Prize. Perspectives in Biology and Medicine 46 (4):532-549.
Rino Rumiati & Nicolao Bonini (2002). Daniel Kahneman: The Nobel Prize for Economics Awarded for Decision-Making Psychology. Mind and Society 3 (1):VII-XI.
Douglas Allchin (2002). To Err and Win a Nobel Prize: Paul Boyer, ATP Synthase and the Emergence of Bioenergetics. [REVIEW] Journal of the History of Biology 35 (1):149 - 172.
Eugene Garfield & Alfred Welljams-Dorof (1992). Of Nobel Class: A Citation Perspective on High Impact Research Authors. Theoretical Medicine and Bioethics 13 (2).
Hub Zwart (2010). The Nobel Prize as a Reward Mechanism in the Genomics Era: Anonymous Researchers, Visible Managers and the Ethics of Excellence. [REVIEW] Journal of Bioethical Inquiry 7 (3):299-312.
Franz Luttenberger (1992). Arrhenius Vs. Ehrlich on Immunochemistry: Decisions About Scientific Progress in the Context of the Nobel Prize. Theoretical Medicine and Bioethics 13 (2).
Frank Portugal (2010). Oswald T. Avery: Nobel Laureate or Noble Luminary? Perspectives in Biology and Medicine 53 (4):558-570.
Added to index2009-01-28
Total downloads3 ( #213,563 of 739,318 )
Recent downloads (6 months)0
How can I increase my downloads?